Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

Liquid biopsy applications

ctDNA for MRD vs conventional surveillance in adjuvant CRC: Either/or? Both?

Date

04 Mar 2025

Session

Liquid biopsy applications

Topics

Clinical Research;  Pathology/Molecular Biology;  Translational Research

Tumour Site

Colon and Rectal Cancer

Presenters

Jeanne Tie

Authors

J. Tie

Author affiliations

  • Medical Oncology Dept., Peter MacCallum Cancer Centre, 3000 - Melbourne/AU

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.